Drug Shortage Report for TAMIFLU
Report ID | 175539 |
Drug Identification Number | 02381842 |
Brand name | TAMIFLU |
Common or Proper name | TAMIFLU |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OSELTAMIVIR |
Strength(s) | 6MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 6MG/ML |
ATC code | J05AH |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-11-24 |
Estimated end date | 2022-12-16 |
Actual end date | 2022-12-09 |
Shortage status | Resolved |
Updated date | 2022-12-12 |
Company comments | Please note Tamiflu 30mg and Tamiflu 45mg are currently available for order with no supply disruptions. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-12 | French | Compare |
v4 | 2022-12-12 | English | Compare |
v3 | 2022-11-25 | English | Compare |
v2 | 2022-11-24 | French | Compare |
v1 | 2022-11-24 | English | Compare |
Showing 1 to 5 of 5